The new Horizon 2020 ELEVATE project for the ‘EarLy dEtection of cerVical cAncer in hard-to-reach populations of women through portable and point-of-care HPV Testing’, has started. The ELEVATE project develops and tests a multi-disciplinary intervention to improve the cervical cancer screening coverage of hard-to-reach women in Europe and the Community of Latin American and Caribbean States. This project combines fundamental scientific research with social science investigations, and technology development. At the core of this project is the development and pilot testing of a portable, point-of care human papillomavirus testing device that yields rapid, easy-to-understand results for use in low-resource settings (i.e. without relying on electrical outlets or trained health personnel). The ELEVATE consortium of nine partners- led by ICRH and CMST of the UGent- will receive 3.3 million Euro from the European Commission’s Horizon 2020 research and innovation programme to execute this project over five years (2019-2023).
More information will follow.